
Rapport Therapeutics Investor Relations Material
Latest events

Investor Day 2025
Rapport Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Rapport Therapeutics Inc
Access all reports
Rapport Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of small-molecule medicines targeting central nervous system disorders. The company's research focuses on understanding neuronal receptor biology to design precision treatments that address the complexities of neurological conditions. By mapping and targeting specific neuronal receptor complexes, Rapport aims to regulate receptor function and expression effectively. The company is headquartered in Boston, Massachusetts, and its shares are listed on NASDAQ.
Key slides for Rapport Therapeutics Inc


Investor Day 2025
Rapport Therapeutics Inc


Investor Day 2025
Rapport Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
RAPP
Country
🇺🇸 United States